E. Anderson

发表

The use of videotaped information in cancer genetic counselling: a randomized evaluation study.

A. Cull, R. Elton, T. Porterfield, 1998, British Journal of Cancer.

European centres Risk reducing mastectomy: outcomes in 10

D. Evans, E. Anderson, D. Evans, 2009 .

Long-Term Attendance at Follow-Up of Women Assessed as Being at Increased Risk of Developing Breast Cancer in South-East Scotland

H. Campbell, M. Porteous, R. Cetnarskyj, 2007, Public Health Genomics.

The development of a psychoeducational intervention for women living with an increased risk of breast cancer.

M. Porteous, M. Watson, A. Cull, 2004, Patient education and counseling.

Patient satisfaction with two different models of cancer genetic services in south-east Scotland

H. Campbell, M. Porteous, R. Cetnarskyj, 2004, British Journal of Cancer.

Factors affecting outcome of patients with impalpable breast cancer detected by breast screening

M. Cunningham, T. Anderson, E. Anderson, 1996, The British journal of surgery.

Retrospective cohort study of breast cancer incidence, health service use and outcomes in Europe: a study of feasibility

Colin Simpson, S. Wild, M. Peltola, 2018, European journal of public health.

Utilisation of Prophylactic Mastectomy in 10 European Centres

M. Beckmann, J. Chang-Claude, P. Møller, 2002, Disease markers.

Guidelines for Follow-Up of Women at High Risk for Inherited Breast Cancer: Consensus Statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer

J. Chang-Claude, K. Heimdal, P. Møller, 2002, Disease markers.

Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.

U. Chetty, A. Forrest, P. Levack, 1989, British Journal of Cancer.

Does local surgery have a role in the management of stage IV breast cancer?

U. Chetty, J. Dixon, A. Carmichael, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A randomised controlled trial of a psychoeducational intervention for women at increased risk of breast cancer

M. Porteous, M. Watson, R. Rush, 2004, British Journal of Cancer.

High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group.

H. Gabra, D. Cameron, U. Chetty, 1996, British Journal of Cancer.

Primary treatment in breast cancer.

U. Chetty, A. Forrest, E. Anderson, 1991, BMJ.

Outcome of the use of acellular-dermal matrix to assist implant-based breast reconstruction in a single centre.

J. Dixon, M. Barber, E. Anderson, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Preoperative systemic treatment of large operable primary breast carcinoma : relationship between tumour characteristics and response to therapy

E. Anderson, 1992 .

The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy.

U. Chetty, A. Forrest, P. Levack, 1988, British Journal of Cancer.

Predicting breast cancer risk: implications of a “weak” family history

M. Longmuir, D. Goudie, N. Bradshaw, 2008, Familial Cancer.

Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold

M. Longmuir, D. Goudie, N. Bradshaw, 2008, British Journal of Cancer.

Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status

A. Howell, P. Møller, D. Evans, 2007, International journal of cancer.

Risk reducing mastectomy: outcomes in 10 European centres

A. Howell, P. Møller, D. Eccles, 2008, Journal of Medical Genetics.

Does the oestrogen receptor concentration of a breast cancer change during systemic therapy?

U. Chetty, A. Forrest, P. Levack, 1990, British Journal of Cancer.

MIB-1 in relation to tumour response and survival in patients with breast cancer treated with primary systemic therapy

D. Cameron, U. Chetty, A. Forrest, 1999 .

Efficacy of Early Diagnosis and Treatment in Women with a Family History of Breast Cancer

K. Heimdal, P. Møller, G. Evans, 2002, Disease Markers.

Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group.

K. Heimdal, P. Møller, G. Evans, 1999, Disease markers.

Efficacy of Early Diagnosis and Treatment in Women with a Family History of Breast Cancer

K. Heimdal, P. Møller, G. Evans, 2002, Disease Markers.

Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy

A. Howell, K. Heimdal, P. Møller, 2002, International journal of cancer.

Use of Cytology to Diagnose Inherited Breast Cancer

K. Heimdal, P. Møller, G. Evans, 2002, Disease Markers.

Role of CASP 8 D 302 H and Other Apoptosis Gene Variants in Breast Cancer Conference or Workshop Item

L. Bingle, D. Goudie, R. Davidson, 2019 .

Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.

D. Cameron, U. Chetty, A. Forrest, 1997, British Journal of Cancer.

A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact

H. Campbell, H. Campbell, M. Porteous, 2003, British Journal of Cancer.

The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress

A. Cull, J. Mackay, M. Steel, 1999, British Journal of Cancer.

Primary systemic therapy for operable breast cancer.

U. Chetty, A. Forrest, T. Anderson, 1991, British Journal of Cancer.

Referrals of women with a family history of breast cancer from primary care to cancer genetics services in South East Scotland

H. Campbell, M. Porteous, R. Cetnarskyj, 2003, British Journal of Cancer.